227 related articles for article (PubMed ID: 15310414)
1. Thymoma and thymic carcinoma: therapeutic approaches.
Kurup A; Loehrer PJ
Clin Lung Cancer; 2004 Jul; 6(1):28-32. PubMed ID: 15310414
[TBL] [Abstract][Full Text] [Related]
2. Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study.
Kirzinger L; Boy S; Marienhagen J; Schuierer G; Neu R; Ried M; Hofmann HS; Wiebe K; Ströbel P; May C; Kleylein-Sohn J; Baierlein C; Bogdahn U; Marx A; Schalke B
PLoS One; 2016; 11(12):e0168215. PubMed ID: 27992479
[TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced thymoma and thymic carcinoma.
Rajan A; Giaccone G
Curr Treat Options Oncol; 2008 Dec; 9(4-6):277-87. PubMed ID: 19381821
[TBL] [Abstract][Full Text] [Related]
4. Thymic epithelial tumor treatment in Japan: analysis of hospital cancer registry and insurance claims data, 2012-2014.
Kanemura H; Tamura T; Nishimura N; Kobayashi D; Higashi T
Jpn J Clin Oncol; 2020 Mar; 50(3):310-317. PubMed ID: 31829410
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric Evaluation of Radiomics Features and Dual-Energy CT Iodine Maps for Discrimination and Outcome Prediction of Thymic Masses.
Mahmoudi S; Gruenewald LD; Eichler K; Althoff FC; Martin SS; Bernatz S; Booz C; Yel I; Kinzler MN; Ziegengeist NS; Torgashov K; Mohammed H; Geyer T; Scholtz JE; Hammerstingl RM; Weber C; Hardt SE; Sommer CM; Gruber-Rouh T; Leistner DM; Vogl TJ; Koch V
Acad Radiol; 2023 Dec; 30(12):3010-3021. PubMed ID: 37105804
[TBL] [Abstract][Full Text] [Related]
6. Thymic Carcinomas-A Concise Multidisciplinary Update on Recent Developments From the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group.
Roden AC; Ahmad U; Cardillo G; Girard N; Jain D; Marom EM; Marx A; Moreira AL; Nicholson AG; Rajan A; Shepherd AF; Simone CB; Strange CD; Szolkowska M; Truong MT; Rimner A
J Thorac Oncol; 2022 May; 17(5):637-650. PubMed ID: 35227908
[TBL] [Abstract][Full Text] [Related]
7. The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposals for the N and the M Components for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.
Fang W; Girard N; Cilento V; Goren E; Dibaba D; Ruffini E; Ahmad U; Appel S; Bille A; Boubia S; Brambilla C; Cangir AK; Detterbeck F; Falkson C; Filosso PL; Giaccone G; Guerrera F; Huang J; Infante M; Kim DK; Lucchi M; Marino M; Marom EM; Nicholson AG; Okumura M; Rami-Porta R; Rimner A; Simone CB; Asamura H;
J Thorac Oncol; 2024 Jan; 19(1):52-70. PubMed ID: 37774950
[TBL] [Abstract][Full Text] [Related]
8. Thymic large cell neuroendocrine carcinoma - a rare and aggressive tumor: a case report.
Boubacar E; Atsame-Ebang G; Rabiou S; Fatimazahra A; Mazti A; Sidibé IS; Tahiri L; Hammas N; Yassine O; Mohamed S; Laila C; Hinde EF
J Med Case Rep; 2017 Jun; 11(1):155. PubMed ID: 28602157
[TBL] [Abstract][Full Text] [Related]
9. Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors.
Tateo V; Manuzzi L; De Giglio A; Parisi C; Lamberti G; Campana D; Pantaleo MA
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260538
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy vs platinum for advanced or metastatic thymic carcinoma: A protocol for systematic review and meta analysis.
Qian J; Tong Z; Zhang Y; Chen C
Medicine (Baltimore); 2021 Jan; 100(3):e23802. PubMed ID: 33545943
[TBL] [Abstract][Full Text] [Related]
11. An Overview of the Use of Anti-Angiogenic Agents in the Treatment of Thymic Epithelial Tumors.
Agrafiotis AC; Berzenji L; Koyen S; Vermeulen D; Winthagen R; Hendriks JMH; Van Schil PE
Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069386
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions.
Rajan A; Sivapiromrat AK; McAdams MJ
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611047
[TBL] [Abstract][Full Text] [Related]
13. What Have We Learned from Molecularly Informed Clinical Trials on Thymomas and Thymic Carcinomas-Current Status and Future Directions?
Maniar R; Loehrer PJ
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254905
[TBL] [Abstract][Full Text] [Related]
14. Thymic malignancies: from clinical management to targeted therapies.
Kelly RJ; Petrini I; Rajan A; Wang Y; Giaccone G
J Clin Oncol; 2011 Dec; 29(36):4820-7. PubMed ID: 22105817
[TBL] [Abstract][Full Text] [Related]
15. Ectopic Cervical Thymoma: An Uncommon Entity.
Kairanna N; Vasudevan G; Karanth V; Sharan K
Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):5884-5887. PubMed ID: 36742565
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of thymomas and thymic carcinomas in the United States and Germany, 1999-2019.
Gerber TS; Strobl S; Marx A; Roth W; Porubsky S
Front Oncol; 2023; 13():1308989. PubMed ID: 38264756
[TBL] [Abstract][Full Text] [Related]
17. GAD1 expression and its methylation as indicators of malignant behavior in thymic epithelial tumors.
Soejima S; Kondo K; Tsuboi M; Muguruma K; Tegshee B; Kawakami Y; Kajiura K; Kawakita N; Toba H; Yoshida M; Takizawa H; Tangoku A
Oncol Lett; 2021 Jun; 21(6):483. PubMed ID: 33968199
[TBL] [Abstract][Full Text] [Related]
18. An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances.
Tateo V; Manuzzi L; Parisi C; De Giglio A; Campana D; Pantaleo MA; Lamberti G
Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33915954
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated Radiotherapy as a Standalone Treatment Modality for Locally Advanced Type B2 Thymoma in an Octogenarian Patient: 45 Gy in 15 Fractions.
Katano A; Kasuga Y; Ohira S; Minamitani M; Yamashita H
Cureus; 2024 Jan; 16(1):e51528. PubMed ID: 38304685
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
